Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Royalty
Welcome,
Profile
Billing
Logout
23 Products
150 Diseases
23 Products
167 Trials
15038 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
15
30
45
60
75
90
105
120
135
150
Tysabri
(natalizumab) / Biogen, Royalty
Adlyxin
(lixisenatide) / Sanofi
Idhifa
(enasidenib) / BMS, Servier
Spinraza
(nusinersen) / Biogen
Trelegy Ellipta
(fluticasone furoate/umeclidinium bromide/vilanterol) / GSK, Innoviva, Theravance Biopharma
Evrysdi
(risdiplam) / SMA Foundation, PTC Therap, Roche
Cobenfy
(xanomeline/trospium) / BMS
Qinprezo
(vosaroxin) / Denovo
omecamtiv mecarbil
(AMG 423) / Amgen, Servier
Niktimvo
(axatilimab-csfr) / Syndax Pharma, Incyte
Skytrofa
(lonapegsomatropin-tcgd) / Ascendis
pelacarsen
(AKCEA-APO(a)-LRx) / Ionis, Novartis
MK-8189
/ Merck (MSD)
Orladeyo
(berotralstat) / BioCryst
ampreloxetine
(TD-9855) / Theravance Biopharma
Adstiladrin
(nadofaragene firadenovec-vncg) / Ferring
Oxlumo
(lumasiran) / Alnylam
Yorvipath
(palopegteriparatide) / Ascendis
olpasiran
(AMG 890) / Amgen
Natroba
(spinosad) / Royalty
deucrictibant immediate-release capsule
(PHVS416) / Pharvaris
olanzapine LAI
(TEV-'749) / Teva, MedinCell
deucrictibant extended-release tablet
(PHVS719) / Pharvaris
trontinemab
(RG6102) / Roche
